Order Article Reprints

Prokopiou DE, Chillà A, Margheri F, Fibbi G, Laurenzana A, Efthimiadou EK. Iron Oxide Nanoparticles: Selectively Targeting Melanoma Cells In Vitro by Inducing DNA Damage via H2AX Phosphorylation and Hindering Proliferation through ERK Dephosphorylation. Pharmaceutics. 2024; 16(4):527. https://doi.org/10.3390/pharmaceutics16040527

Prokopiou, Danai E., Anastasia Chillà, Francesca Margheri, Gabriella Fibbi, Anna Laurenzana, and Eleni K. Efthimiadou. 2024. "Iron Oxide Nanoparticles: Selectively Targeting Melanoma Cells In Vitro by Inducing DNA Damage via H2AX Phosphorylation and Hindering Proliferation through ERK Dephosphorylation" Pharmaceutics 16, no. 4: 527. https://doi.org/10.3390/pharmaceutics16040527

Prokopiou, D. E., Chillà, A., Margheri, F., Fibbi, G., Laurenzana, A., & Efthimiadou, E. K. (2024). Iron Oxide Nanoparticles: Selectively Targeting Melanoma Cells In Vitro by Inducing DNA Damage via H2AX Phosphorylation and Hindering Proliferation through ERK Dephosphorylation. Pharmaceutics, 16(4), 527. https://doi.org/10.3390/pharmaceutics16040527